211 related articles for article (PubMed ID: 36325600)
21. [Potentially malignant disorders of the oral mucosa: terminology and classification].
Ben Slama L
Rev Stomatol Chir Maxillofac; 2010 Sep; 111(4):208-12. PubMed ID: 20739038
[TBL] [Abstract][Full Text] [Related]
22. Potentially Malignant Oral Disorders and Cancer Transformation.
Ganesh D; Sreenivasan P; Öhman J; Wallström M; Braz-Silva PH; Giglio D; Kjeller G; Hasséus B
Anticancer Res; 2018 Jun; 38(6):3223-3229. PubMed ID: 29848669
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
24. [Leukoplakia and erythroplakia--two orale precursor lesions].
Grajewski S; Groneberg D
Laryngorhinootologie; 2009 Oct; 88(10):666-72; quiz 673-5. PubMed ID: 19813163
[TBL] [Abstract][Full Text] [Related]
25. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
[TBL] [Abstract][Full Text] [Related]
26. Revisiting the evidence of photodynamic therapy for oral potentially malignant disorders and oral squamous cell carcinoma: An overview of systematic reviews.
Schuch LF; Schmidt TR; Kirschnick LB; de Arruda JAA; Campagnol D; Martins MAT; Santos-Silva AR; Lopes MA; Vargas PA; Bagnato VS; Kurachi C; Guerra ENS; Martins MD
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103531. PubMed ID: 36963644
[TBL] [Abstract][Full Text] [Related]
27. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
[TBL] [Abstract][Full Text] [Related]
28. Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: A prospective cohort study of Taiwanese nationwide oral cancer screening program.
Chuang SL; Wang CP; Chen MK; Su WW; Su CW; Chen SL; Chiu SY; Fann JC; Yen AM
Oral Oncol; 2018 Dec; 87():58-63. PubMed ID: 30527244
[TBL] [Abstract][Full Text] [Related]
29. Regular clinical follow-up of oral potentially malignant disorders results in improved survival for patients who develop oral cancer.
Jäwert F; Nyman J; Olsson E; Adok C; Helmersson M; Öhman J
Oral Oncol; 2021 Oct; 121():105469. PubMed ID: 34371451
[TBL] [Abstract][Full Text] [Related]
30. Myofibroblasts in oral potentially malignant disorders: Is it related to malignant transformation?
Coletta RD; Salo T
Oral Dis; 2018 Mar; 24(1-2):84-88. PubMed ID: 29480603
[TBL] [Abstract][Full Text] [Related]
31. The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia.
Wils LJ; Poell JB; Peferoen LAN; Evren I; Brouns ER; de Visscher JGAM; van der Meij EH; Brakenhoff RH; Bloemena E
J Oral Pathol Med; 2023 Nov; 52(10):930-938. PubMed ID: 37749621
[TBL] [Abstract][Full Text] [Related]
32. Oral cancer and oral potentially malignant disorders in patients with Fanconi anemia - A systematic review.
Santana NCM; de Sena ACVP; Rocha PADS; de Arruda JAA; Torres-Pereira CC; Abreu LG; Fournier BPJ; Warnakulasuriya S; Silva TA
Oral Oncol; 2024 Mar; 150():106699. PubMed ID: 38309198
[TBL] [Abstract][Full Text] [Related]
33. Podoplanin and ABCG2 expression in oral erythroplakia revisited: Potential evidence for cancer stem cells driving the process of field cancerization.
Yang X; Shi L; Zhou Z; Liu W
Oral Oncol; 2020 Feb; 101():104368. PubMed ID: 31300272
[TBL] [Abstract][Full Text] [Related]
34. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
35. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
[TBL] [Abstract][Full Text] [Related]
36. Prognostic outcomes of oral squamous cell carcinoma derived from proliferative verrucous leukoplakia: A systematic review.
Faustino ISP; de Pauli Paglioni M; de Almeida Mariz BAL; Normando AGC; Pérez-de-Oliveira ME; Georgaki M; Nikitakis NG; Vargas PA; Santos-Silva AR; Lopes MA
Oral Dis; 2023 May; 29(4):1416-1431. PubMed ID: 35199416
[TBL] [Abstract][Full Text] [Related]
37. Comparison of PD-L1 Expression in Oral Squamous Cell Carcinoma and Premalignant Lesions of Oral Cavity.
Saeed S; Rauf F; Iqbal F; Khan AS; Khan AH; Alamgeer R
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4039-4045. PubMed ID: 36579984
[TBL] [Abstract][Full Text] [Related]
38. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology.
Müller S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):591-602. PubMed ID: 29606637
[TBL] [Abstract][Full Text] [Related]
39. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia.
Ries J; Vairaktaris E; Agaimy A; Bechtold M; Gorecki P; Neukam FW; Nkenke E
Oncol Rep; 2013 Sep; 30(3):1149-56. PubMed ID: 23784518
[TBL] [Abstract][Full Text] [Related]
40. Evolution tumour models paving the way for understanding oral carcinogenesis.
Martins-Chaves RR; Silva RSO; Pereira TDSF; Fonseca FP; Gomez RS
J Oral Pathol Med; 2023 Apr; 52(4):294-299. PubMed ID: 36622735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
